We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dark Chocolate Reduces ACE Activity and May Lower Heart Attack Risk

By LabMedica International staff writers
Posted on 01 Dec 2010
Eating as little as 75 grams of dark chocolate reduces the activity of angiotensin-converting enzyme (ACE) while increasing levels of nitric oxide (NO), which suggests that including chocolate in the diet may ultimately help reduce hypertension and its related risk of cardiovascular disease.

Investigators at Linköping University (Sweden) wanted to determine if cocoa extract and dark chocolate would influence ACE and NO in human endothelial cells (in vitro) and in healthy volunteers (in vivo). More...


ACE activity was analyzed with a commercial radioenzymatic assay and measured in human endothelial cells from umbilical veins (HUVEC) after a 10-minute incubation with cocoa extract. NO was measured after 24 hours incubation. In 16 healthy volunteers ACE activity and NO were measured at baseline and after 30, 60 and 180 minutes after a single intake of 75 g dark chocolate containing 72% cocoa. The volunteers were not tobacco users and were not allowed to take any pharmaceuticals for the two weeks prior to the experiment. During the last two days, they were not allowed to eat chocolate or any foods containing similar compounds, including many kinds of berries and fruits, nor could they drink coffee, tea, or wine.

Results published in the October 14, 2010, online edition of the Journal of Cardiovascular Pharmacology revealed that in the HUVEC significant inhibition of ACE activity and significant increase of NO were seen. In the human volunteers, a significant inhibition of ACE activity (mean 18%) three hours after intake of dark chocolate was measured, but no significant change in NO was seen.

"We have previously shown that green tea inhibits the enzyme ACE, which is involved in the body's fluid balance and blood pressure regulation. Now we wanted to study the effect of cocoa, since the active substances catechins and procyanidines are related,” said first author Dr. Ingrid Persson, professor of pharmacology at Linköping University. "Our findings indicate that changes in lifestyle with the help of foods that contain large concentrations of catechins and procyaninides prevent cardiovascular diseases.”

Related Links:
Linköping University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.